TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2025

ReNeu: A Pivotal, Phase IIb Trial of Mirdametinib in Adults and Children With Symptomatic Neurofibromatosis Type 1-Associated Plexiform Neurofibroma.

Christopher L Moertel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.